Australia’s University of Queensland (U.Q.) and Canada’s PreveCeutical Medical Inc. have teamed up for what is being called a revolutionary change in how patients will take medical cannabis: a liquid that converts to a gel.
Story continues below
This advertisement has not loaded yet, but your article continues below.
The Sol-Gel technology is thanks to the work of a team of researchers, led by Dr. Harendra Parekh, at the U.Q.’s School of Pharmacy, which explains the liquid solution converts to a gel upon contacting “internal membranes of the human body, such as the nose.”
Vancouver-headquartered PreveCeutical — which, along with its partners, researches and develops solutions that give consumers options for preventive and curative therapies — will have a
Read full article on The Growth Op
